Naplox 0.1%w/v Eye Drop 5ml
Out of Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Naplox 0.1%w/v Eye Drop 5ml also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Naplox 0.1%w/v Eye Drop 5ml
It includes Nepafenac. Nepafenac is an ophthalmic nonsteroidal anti-inflammatory drug (NSAID) used to relieve eye pain and inflammation after cataract surgery.
How Naplox 0.1%w/v Eye Drop 5ml works
Nepafenac inhibits the activity of cyclooxygenase (COX) enzymes, reducing the production of prostaglandins, which are responsible for inflammation and pain in the eyes.
How To Use Naplox 0.1%w/v Eye Drop 5ml
- Apply one drop to the affected eye(s) three times daily, starting one day before surgery and continuing for two weeks after the surgery.
Special Precautions for Naplox 0.1%w/v Eye Drop 5ml
- Avoid use if you have known allergies to NSAIDs.
- Use cautiously if you have bleeding disorders or are prone to eye infections.
Benefits Of Naplox 0.1%w/v Eye Drop 5ml
- Reduces inflammation and pain after eye surgery.
- Promotes faster recovery post-surgery.
Side Effects Of Naplox 0.1%w/v Eye Drop 5ml
- Blurred vision
- Eye irritation
What If I Missed A Dose Of Naplox 0.1%w/v Eye Drop 5ml
- Apply the missed dose as soon as you remember, but skip it if it's near the time for the next dose.
- Do not double the dose.
Health And Lifestyle
Drug Interaction
- Dexamethasone
- Ibuprofen
Disease Explanation
Cataracts: A clouding of the eye's lens that impairs vision, typically corrected through surgery. Postoperative Inflammation: Swelling and irritation in the eye following surgery, often treated with anti-inflammatory medications like nepafenac.
Safety Advice for Naplox 0.1%w/v Eye Drop 5ml
- High risk
- Moderate risk
- Safe
Safe to consume in moderation.
Avoid driving if you experience blurred vision.
Should be avoided unless absolutely necessary.
Caution advised for patients with liver disease.
Use with caution in kidney impairment.
Not recommended unless clearly needed.
Written By
Salony Priya
MBA in pharmaceutical management
Content Updated on
Saturday, 7 September, 2024
